Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapsone as a steroid-sparing agent in pemphigus vulgaris
NCT00429533Phase 2Terminated
- Sponsor
- Jacobus Pharmaceutical Company Inc.
- Start
- Nov 1996
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dapsone in pemphigus vulgaris (PV), sponsored by Jacobus Pharmaceutical Company Inc.. Started Nov 1996; status: terminated.
02
Drugs
dapsone
03
Conditions
pemphigus vulgaris (PV)
Beyond the preview
Go deeper on NCT00429533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429533.